retatrutide clinical trials mechanism Retatrutide's mechanisms of action Substack Series 3 of 6:

however, cells expressing hGPR17L had significantly reduced GLP-1 secretion under both vehicle and F/I stimulated conditions (Figure 3A), suggesting that constitutive GPR17 activity inhibits GLP-1 secretion

Some of that may be just the makeup of the studies, rather than the actual data itself. From a cancer prevention perspective, I think more data is needed, Chiang said, noting that theres also a lack of data on GLP-1 usage among patients who already have cancer

Consistent with FDA labeling, GLP-1 RAs amplify hypoglycemia risk when combined with insulin or sulfonylureas 42 , a complication linked to seizures, syncope, and tremors 43

Its hard when something you love suddenly turns on you